Literature DB >> 11302830

Vancomycin and ceftazidime bioactivities persist for at least 2 weeks in the lumen in ports: simplifying treatment of port-associated bloodstream infections by using the antibiotic lock technique.

Y Haimi-Cohen1, N Husain, J Meenan, G Karayalcin, M Lehrer, L G Rubin.   

Abstract

The residual antibiotic concentration of vancomycin (2 mg/ml)- or ceftazidime (2 mg/ml)-heparin solutions instilled in ports in pediatric hematology-oncology patients 1 to 34 days earlier was measured. Antibiotic concentrations of > or = 100 microg of either antibiotic per ml persisted for at least 21 days. For treatment of lumenal port infections, antibiotic-heparin dwell times of > or = 2 weeks may be appropriate.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11302830      PMCID: PMC90508          DOI: 10.1128/AAC.45.5.1565-1567.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  Cure of implantable venous port-associated bloodstream infections in pediatric hematology-oncology patients without catheter removal.

Authors:  L G Rubin; S Shih; A Shende; G Karayalcin; P Lanzkowsky
Journal:  Clin Infect Dis       Date:  1999-07       Impact factor: 9.079

2.  Morbidity associated with long-term use of totally implantable ports in patients with AIDS.

Authors:  P Domingo; A Fontanet; F Sánchez; L Allende; G Vazquez
Journal:  Clin Infect Dis       Date:  1999-08       Impact factor: 9.079

3.  Stability of antibiotics used for antibiotic-lock treatment of infections of implantable venous devices (ports).

Authors:  T U Anthony; L G Rubin
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

Review 4.  Catheter-sepsis during home parenteral nutrition: use of the antibiotic-lock technique.

Authors:  B Messing
Journal:  Nutrition       Date:  1998-05       Impact factor: 4.008

5.  Bloodstream infection from a Port-A-Cath: successful treatment with the antibiotic lock technique.

Authors:  T Bregenzer; A F Widmer
Journal:  Infect Control Hosp Epidemiol       Date:  1996-12       Impact factor: 3.254

6.  Totally implantable venous access device infections in patients with AIDS.

Authors:  M Hellard; A Fuller; D Spelman; W J Spicer; R Pickles; A Jenney
Journal:  AIDS       Date:  1997-04       Impact factor: 4.177

7.  An experience with an implanted port system in 66 children with cancer.

Authors:  D L Becton; M Kletzel; E S Golladay; G Hathaway; D H Berry
Journal:  Cancer       Date:  1988-01-15       Impact factor: 6.860

8.  A new approach to the management of Broviac catheter infection.

Authors:  J S Rao; A O'Meara; T Harvey; F Breatnach
Journal:  J Hosp Infect       Date:  1992-10       Impact factor: 3.926

9.  A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients.

Authors:  B U Mueller; J Skelton; D P Callender; D Marshall; J Gress; D Longo; J Norton; M Rubin; D Venzon; P A Pizzo
Journal:  J Clin Oncol       Date:  1992-12       Impact factor: 44.544

10.  Antibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients.

Authors:  B Messing; S Peitra-Cohen; A Debure; M Beliah; J J Bernier
Journal:  JPEN J Parenter Enteral Nutr       Date:  1988 Mar-Apr       Impact factor: 4.016

View more
  6 in total

1.  Comparison of different doses of vancomycin andteicoplanin lock solutions in catheters colonized with Staphylococcus epidermidis: An in vitro, blinded, antibiotic lock study.

Authors:  Serkan Oncu; Serhan Sakarya
Journal:  Curr Ther Res Clin Exp       Date:  2005-07

2.  Prophylaxis of catheter-related bacteremia using tissue plasminogen activator-tobramycin locks.

Authors:  Ali Mirza Onder; Jayanthi Chandar; Anthony Billings; Nancy Simon; JoAnn Gonzalez; Denise Francoeur; Carolyn Abitbol; Gaston Zilleruelo
Journal:  Pediatr Nephrol       Date:  2009-07-10       Impact factor: 3.714

3.  Treatment of catheter-related bacteremia with tissue plasminogen activator antibiotic locks.

Authors:  Ali Mirza Onder; Jayanthi Chandar; Nancy Simon; Marie Saint-Vil; Denise Francoeur; Obioma Nwobi; Carolyn Abitbol; Gaston Zilleruelo
Journal:  Pediatr Nephrol       Date:  2007-12-06       Impact factor: 3.714

4.  Comparison of early versus late use of antibiotic locks in the treatment of catheter-related bacteremia.

Authors:  Ali Mirza Onder; Jayanthi Chandar; A A Billings; Nancy Simon; Rosa Diaz; Denise Francoeur; Carolyn Abitbol; Gaston Zilleruelo
Journal:  Clin J Am Soc Nephrol       Date:  2008-04-09       Impact factor: 8.237

5.  Decreasing gradient of antibiotic concentration in the lumen of catheters locked with vancomycin.

Authors:  A Soriano; E Bregada; J M Marqués; M Ortega; A Bové; J A Martínez; J Mensa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-09       Impact factor: 3.267

Review 6.  Antibiotic lock therapy: review of technique and logistical challenges.

Authors:  Julie Ann Justo; P Brandon Bookstaver
Journal:  Infect Drug Resist       Date:  2014-12-12       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.